A RANDOMISED CONTROLLED STUDY OF INTRAMUSCULAR ACETAMINOPHEN- DICLOFENAC VERSUS ACETAMINOPHEN-PENTAZOCINE FOR PAIN RELIEF DURING MANUAL VACUUM ASPIRATION IN UNIVERSITY OF MAIDUGURI TEACHING HOSPITAL

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

PACTR

Registry ID

PACTR202209818432344

Enrollment

112

Registered

2022-09-15

Start date

2022-04-19

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pregnancy and Childbirth

Interventions

GROUP B ACETAMINOPHENEPENTAZOCIN GROUP

GROUP A ACETAMINOPHEN DICLOFENAC

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: 1) Women diagnosed with miscarriage clinically and/or by pelvic ultrasound scan at a gestational age of 12 weeks or less that requires MVA. 2) Patients that are informed, counselled, and consented to participate in the study.

Exclusion criteria

Exclusion criteria: 1) Known peptic ulcer disease patients 2) Allergic reaction to pentazocine, diclofenac and acetaminophen. 3) Septic or hypovolemic shock 4) Patients with chronic liver or kidney disease 5) Known coagulation disorder 6) Patient’s refusal

Design outcomes

Primary

Measure	Time frame
The primary outcome will be to determine and compare participant pain perception, when either combined intramuscular acetaminophen-diclofenac or acetaminophen-pentazocine is given for pain relief during manual vacuum aspiration.	—

Secondary

Measure	Time frame
Secondary outcomes will be the need for rescue analgesia (intramuscular tramadol 100 mg), incidence of dizziness, nausea, vomiting, and participant satisfaction with analgesia regimen used.	—

Countries

Nigeria

Contacts

Public ContactANGELA CHIKAODILI IHEFOBI

POSITION

angelachika18@gmail.com08104351088

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Aug 9, 2026